Seelos Therapeutics, Inc. Research and Development in Process
Seelos Therapeutics, Inc. reported Research and Development in Process of $204.90 thousand for the 12-month period ending 2010-12-31, per its 10-K filed 2012-03-13.
Discontinued › Notes
us-gaap:ResearchAndDevelopmentInProcess · last filed 2012-03-13
- Seelos Therapeutics, Inc. research and development in process for fiscal 2010 was $204.90K.
| Period end | Research and Development in Process 12 month |
|---|---|
| 2010-12-31 | $204.90K 10-K · filed 2012-03-13 |